VENUSREM.NS
Key Ratios

Net Profit Margin: Making very low profit as compared to its revenue which generally means either business is inefficient or cost of making the product or services is higher than what it is finally worth

Acid Test Ratio: It has very strong liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Average efficiency of inventory movement, it varies by industry

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: Fairly valued stock which is a sign of mature companies

Performance Graph
Financial Ratios
Ratio Value
PE Ratio14.55
Net Profit Margin0.05
Acid Test Ratio2.99
Inventory Turnover3.07
Coverage Ratio477.45
Debt to Equity0.08
Key Ratios

Net Profit Margin: Making very low profit as compared to its revenue which generally means either business is inefficient or cost of making the product or services is higher than what it is finally worth

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: Very low income of the company when compared with its equity, which means inefficient equity

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.05
Return on Assets1.65
Return on Equity0.06
Performance Graph
Key Ratios

Acid Test Ratio: It has very strong liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It would not have any issues to cover its short-term liabilities because of strong liquidity

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio2.99
Current Ratio4.53
Performance Graph
Key Ratios

Inventory Turnover: Average efficiency of inventory movement, it varies by industry

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover3.07
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio477.45
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.08
Interest Coverage Ratio477.45
Performance Graph
Key Ratios

P/E Ratio: Fairly valued stock which is a sign of mature companies

Dividend Yield: NA

Performance Graph
Market Ratios
Ratio Value
P/E Ratio14.55
Gross Profit Margin0.37
Price to Book Ratio0.85
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Venus Remedies Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 6268218000 6010800000 5798180000
Total Non Current Assets 2673004000 2782450000 3017782000
Other Non Current Assets 7000 2000 4000
Non Current Prepaid Assets 222751000 330572000 329715000
Non Current Deferred Taxes Assets - - 6821000
Financial Assets - - -
Investment In Financial Assets 7172000 1210000 15676000
Held To Maturity Securities - - -
Available For Sale Securities 7172000 1210000 15676000
Financial Assets Fair Value - - -
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets 852109000 792461000 879286000
Other Intangible Assets 852109000 792461000 879286000
Goodwill - - -
Net Ppe 1552958000 1637087000 1786280000
Accumulated Depreciation -2719297000 -2697778000 -2623255000
Gross Ppe 4272255000 4334865000 4409535000
Construction In Progress 621334000 671534000 657819000
Other Properties 1084529000 1087164000 1077705000
Machinery Furniture Equipment 1438041000 1537125000 1638030000
Buildings And Improvements 1010808000 925002000 921941000
Land And Improvements 117543000 114040000 114040000
Properties - - -
Current Assets 3595214000 3228350000 2780398000
Other Current Assets 395200000 1000 344060000
Hedging Assets Current - - -
Assets Held For Sale Current - - -
Restricted Cash 33739000 25035000 71403000
Prepaid Assets 320154000 186598000 290141000
Inventory 1216936000 1199413000 1256439000
Other Inventories - - -
Finished Goods 245821000 173637000 160730000
Work In Process 201426000 248197000 340416000
Raw Materials 769689000 777579000 755293000
Other Receivables 12085000 11497000 48317000
Taxes Receivable 369275000 318441000 295539000
Accounts Receivable 804977000 766597000 386003000
Allowance For Doubtful Accounts Receivable -606000 - -
Gross Accounts Receivable 805583000 766597000 -
Cash Cash Equivalents And Short Term Investments 838048000 720768000 432556000
Other Short Term Investments 348493000 508647000 20549000
Cash And Cash Equivalents 489555000 212121000 432556000
Cash Equivalents 343691000 - 229500000
Cash Financial 145864000 212121000 203056000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt - 210810000 -
Total Debt 413252000 422931000 428450000
Total Liabilities Net Minority Interest 1392717000 1407439000 1393716000
Total Non Current Liabilities Net Minority Interest 598559000 581737000 466331000
Other Non Current Liabilities - - 3000
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans 102576000 88456000 79539000
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities 109194000 106492000 -
Long Term Debt And Capital Lease Obligation 386789000 386789000 386789000
Long Term Capital Lease Obligation - - -
Long Term Debt 386789000 386789000 386789000
Long Term Provisions 102600000 88500000 79540000
Current Liabilities 794158000 825702000 927385000
Other Current Liabilities 15800000 10909000 11666000
Current Deferred Taxes Liabilities - - -
Current Debt And Capital Lease Obligation 26463000 36142000 41661000
Current Capital Lease Obligation - - -
Current Debt 26463000 36142000 41661000
Pension And Other Post Retirement Benefit Plans Current 10539000 8859000 7473000
Current Provisions 10500000 8900000 7473000
Payables 709557000 725528000 747010000
Other Payable 268120000 217127000 245343000
Dividends Payable - - -
Total Tax Payable - - -
Accounts Payable 441437000 508401000 501667000
Common Stock Equity 4875501000 4603361000 4404464000
Total Capitalization 5262290000 4990150000 4791253000
Total Equity Gross Minority Interest 4875501000 4603361000 4404464000
Minority Interest - - -
Stockholders Equity 4875501000 4603361000 4404464000
Other Equity Interest 4741800000 4469700000 4270800000
Treasury Stock - - -
Retained Earnings 1704314000 1421279000 1160245000
Additional Paid In Capital 883283000 883283000 883283000
Capital Stock 133670000 133670000 133670000
Common Stock 133670000 133670000 133670000

Income statement interpretation for Venus Remedies Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 5914496000 5533797000 5986485000
Operating Revenue 5914496000 5533797000 5986485000
Cost Of Revenue 3731911000 3453616000 3997681000
Gross Profit 2182585000 2080181000 1988804000
Ebitda 711801000 703462000 701399000
Ebit 447370000 380484000 366061000
Operating Income 331574000 277267000 285803000
Net Income 284908000 265658000 407242000
Net Income From Continuing Operation Net Minority Interest 284908000 265658000 407242000
Net Income From Continuing And Discontinued Operation 284908000 265658000 407242000
Net Income Common Stockholders 284908000 265658000 407242000
Net Income Including Noncontrolling Interests 284908000 265658000 407242000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 284908000 265658000 407242000
Normalized Income 281312972 265599166 407242000
Normalized Ebitda 706288000 703378000 701399000
Total Unusual Items 5513000 84000 -
Total Unusual Items Excluding Goodwill 5513000 84000 -
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 264431000 322978000 335338000
Reconciled Cost Of Revenue 3731911000 3453616000 3997681000
Total Expenses 5582922000 5256530000 5700682000
Operating Expense 1851011000 1802914000 1703001000
Other Operating Expenses 21724000 14485000 13516000
Depreciation And Amortization In Income Statement 264431000 322978000 335338000
Amortization 90454000 87638000 87638000
Depreciation Income Statement 173977000 235340000 247700000
Selling General And Administration 785763000 640617000 573642000
Selling And Marketing Expense 658074000 525063000 489509000
General And Administrative Expense 127689000 115554000 84133000
Rent And Landing Fees 5651000 4020000 3770000
Tax Provision 161525000 113646000 -43161000
Pretax Income 446433000 379304000 364081000
Other Non Operating Income Expenses 9091000 10901000 10775000
Special Income Charges - - -
Other Special Charges - - -
Write Off - - -
Net Non Operating Interest Income Expense 40719000 17809000 4400000
Total Other Finance Cost - 1422000 1780000
Interest Expense Non Operating 937000 1180000 1980000
Interest Income Non Operating 41656000 18989000 8160000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 21.31 19.88 30.86
Basic Eps 21.31 19.88 30.86
Diluted Ni Avail To Com Stockholders 284908000 265658000 407242000
Net Income From Continuing Operations 446433000 379304000 364081000
Minority Interests - - -

Cash flow analysis for Venus Remedies Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 372853000 366274000 411018000
Changes In Cash 289933000 -147697000 148978000
Taxes Refund Paid -154827000 - -
Change In Working Capital -121092000 -246336000 -216378000
Change In Other Current Liabilities 319513000 609815000 336799000
Change In Other Current Assets -456404000 -861827000 -562066000
Change In Payable - - -
Change In Inventory - - -
Change In Receivables - - -
Other Non Cash Items -44611000 -21517000 -9889000
Stock Based Compensation - - -
Provision And Write Off Of Assets 606000 - -
Depreciation And Amortization 264431000 322978000 335338000
Amortization Cash Flow 90454000 87638000 87638000
Depreciation 173977000 235340000 247700000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -72093000 -508296000 -167269000
Net Other Investing Changes 8718000 4443000 -129403000
Interest Received Cfi 41656000 18989000 8160000
Dividends Received Cfi - - -
Net Investment Purchase And Sale 12711000 -453548000 -46026000
Sale Of Investment 12711000 84000 -
Purchase Of Investment - -453632000 -46026000
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -93182000 -78180000 -
Sale Of Ppe - - -
Purchase Of Ppe -93182000 -78180000 -
Net Intangibles Purchase And Sale -41996000 - -
Purchase Of Intangibles -41996000 - -
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow -10827000 -5675000 -94771000
Net Other Financing Charges 1000 - -2835000
Interest Paid Cff -937000 -1180000 -1780000
Cash Dividends Paid - - -
Common Stock Dividend Paid - - -
Net Common Stock Issuance - - -
Common Stock Payments - - -
Common Stock Issuance - - -
Repurchase Of Capital Stock - - -
Repayment Of Debt -9891000 -4495000 -90156000
Issuance Of Debt - - -
Issuance Of Capital Stock - - -
Net Issuance Payments Of Debt -9891000 -4495000 -90156000
Net Short Term Debt Issuance - - -
Short Term Debt Issuance - - -
Net Long Term Debt Issuance -9891000 -4495000 -90156000
Long Term Debt Payments -9891000 -4495000 -90156000
Long Term Debt Issuance - - -
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of VENUSREM.NS (Venus Remedies Limited)

Above is the summary for fundamental analysis of Venus Remedies Limited , whose ticker name is VENUSREM.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Venus Remedies Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 14.55, VENUSREM.NS has a net profit margin of 0.05, the acid test ratio for VENUSREM.NS is 2.99, VENUSREM.NS has an inventory turnover of 3.07, and VENUSREM.NS has debt-to-equity ratio of 0.08.

The VENUSREM.NS whose company name is Venus Remedies Limited has made profit/loss of 2182585000 with total revenue of 5914496000, VENUSREM.NS has assets worth of 6268218000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter